Response Biomed Corp RPBIF

RE: Response regains worldwide rights...

[dimar66]

So now 3M is going to write off their investment in Ramp, probably just not enough revenue to hold their interest. It is ending in a not too bad of a way however as RBM is getting access to the marketing network which has value and it could be that a smaller company could manage this better.   This may dovetail in with the current plans to market independently Ramp cardiac products in the States.   I would guess that 3M would also want to dump their shares as well to be able to write off the loss.